OppenheimerFunds Inc. cut its position in Danaher Corporation (NYSE:DHR) by 18.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,474,093 shares of the conglomerate’s stock after selling 335,079 shares during the period. OppenheimerFunds Inc. owned 0.21% of Danaher Corporation worth $126,079,000 as of its most recent filing with the SEC.
Several other hedge funds have also bought and sold shares of DHR. United Services Automobile Association raised its stake in Danaher Corporation by 14.8% in the first quarter. United Services Automobile Association now owns 413,905 shares of the conglomerate’s stock worth $35,401,000 after buying an additional 53,494 shares during the last quarter. Findlay Park Partners LLP increased its position in Danaher Corporation by 28.1% in the first quarter. Findlay Park Partners LLP now owns 2,692,348 shares of the conglomerate’s stock valued at $230,277,000 after buying an additional 590,000 shares during the period. ZWJ Investment Counsel Inc. bought a new position in Danaher Corporation during the first quarter valued at $723,000. Municipal Employees Retirement System of Michigan increased its position in Danaher Corporation by 0.9% in the first quarter. Municipal Employees Retirement System of Michigan now owns 19,640 shares of the conglomerate’s stock valued at $1,680,000 after buying an additional 180 shares during the period. Finally, Exchange Capital Management Inc. bought a new position in Danaher Corporation during the first quarter valued at $210,000. 76.12% of the stock is owned by institutional investors and hedge funds.
Shares of Danaher Corporation (NYSE:DHR) traded down 0.05% during midday trading on Friday, reaching $80.87. The company’s stock had a trading volume of 2,861,306 shares. The company has a 50 day moving average price of $82.32 and a 200-day moving average price of $84.22. The stock has a market capitalization of $56.18 billion, a PE ratio of 25.81 and a beta of 1.03. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.01.
Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.97 by $0.02. The business had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business’s revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.90 EPS. On average, equities research analysts expect that Danaher Corporation will post $3.95 EPS for the current year.
WARNING: This article was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.com-unik.info/2017/08/19/oppenheimerfunds-inc-has-126-08-million-position-in-danaher-corporation-nysedhr-updated-updated-updated.html.
A number of research firms have commented on DHR. Wells Fargo & Company began coverage on Danaher Corporation in a report on Thursday, July 13th. They set a “market perform” rating and a $90.00 price target on the stock. Jefferies Group LLC reissued a “buy” rating and set a $95.00 price target on shares of Danaher Corporation in a report on Friday, August 4th. BidaskClub cut Danaher Corporation from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 1st. Zacks Investment Research cut Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. Finally, BTIG Research reissued a “buy” rating and set a $92.00 price target on shares of Danaher Corporation in a report on Sunday, April 23rd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $91.76.
In other news, SVP Angela S. Lalor sold 10,815 shares of the firm’s stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the completion of the sale, the senior vice president now owns 39,020 shares in the company, valued at approximately $3,283,923.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider William King sold 7,458 shares of the firm’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $82.97, for a total transaction of $618,790.26. Following the sale, the insider now owns 18,245 shares of the company’s stock, valued at approximately $1,513,787.65. The disclosure for this sale can be found here. Insiders have sold a total of 38,623 shares of company stock valued at $3,206,426 in the last 90 days. Insiders own 12.20% of the company’s stock.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.